Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · Real-Time Price · USD
0.5480
-0.0019 (-0.35%)
At close: Aug 10, 2026, 4:00 PM EDT
0.5100
-0.0380 (-6.93%)
After-hours: Aug 10, 2026, 8:00 PM EDT

Oragenics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---0.040.130.09
Revenue Growth
----71.37%51.20%-
Gross Profit
---0.040.130.09
Operating Income
-9.59-9.36-10.56-20.9-14.42-15.77
Net Income
-9.83-9.84-10.57-20.66-14.29-15.71
Earnings Per Share
-4.97-4.56-47.88-275.40-213.30-242.70
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
6.118.40.863.4811.4327.27
Total Debt
0.060.230.330.320.620.8
Net Cash (Debt)
6.058.170.543.1610.826.47
Net Cash Growth
598.16%1423.81%-83.03%-70.74%-59.19%58.11%
Net Cash Per Share
2.243.792.4342.15161.29408.65

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-9.33-9.25-8.6-7.29-15.23-13.47
Capital Expenditures
-----0.13-0.04
Free Cash Flow
-9.33-9.25-8.6-7.29-15.36-13.51
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---100.00%100.00%100.00%
Operating Margin
----55519.90%-10964.60%-18130.30%
Pretax Margin
----54858.14%-10863.96%-18062.03%
Profit Margin
----54858.10%-10864.00%-18062.00%
FCF Margin
----19363.30%-11675.70%-15535.80%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
---460.6397.07596.77